CME Group Inc. vs. NVIDIA Corporation
NVIDIA Corporation (NVDA) comes out ahead, leading on 6 of 11 compared factors.
Size & Scale
| CME | NVDA | |
|---|---|---|
| Market Cap | $97.40 billion | $5.25 trillion |
| Revenue (TTM) | $6.77 billion | $253.49 billion |
| Net Income (TTM) | $4.29 billion | $159.61 billion |
NVDA leads on 3 of 3 size & scale factors.
Valuation
| CME | NVDA | |
|---|---|---|
| P/E Ratio | 23.32 | 32.88 |
| Price / Book | 3.67 | 26.87 |
| Price / Sales | 14.38 | 20.72 |
CME leads on 3 of 3 valuation factors.
Profitability
| CME | NVDA | |
|---|---|---|
| Net Margin | 63.30% | 62.97% |
| Return on Equity | 16.16% | 81.65% |
CME and NVDA split the profitability factors evenly.
Dividend
| CME | NVDA | |
|---|---|---|
| Dividend Yield | 1.89% | 0.47% |
| Payout Ratio | 44.11 | 15.31 |
CME and NVDA split the dividend factors evenly.
Risk & Sentiment
| CME | NVDA | |
|---|---|---|
| Short Interest | 1.18% | 0.07% |
NVDA leads on 1 of 1 risk & sentiment factors.
Dig deeper: CME overview, CME financials, NVDA overview, NVDA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.